Get startedLog in
    Picture of Biovaxys Technology logo

    BIOV — Biovaxys Technology Income Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Biovaxys Technology, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

    2020
    October 31st
    2021
    October 31st
    2022
    October 31st
    2023
    October 31st
    2024
    October 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Total Revenue00000
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Total Operating Expenses1.16.4411.77.865.03
    Operating Profit-1.1-6.44-11.7-7.86-5.03
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-1.1-6.46-11.7-7.69-3.95
    Net Income After Taxes-1.1-6.46-11.7-7.69-3.95
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income-1.17-6.46-11.7-7.69-3.95
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-1.17-6.46-11.7-7.69-3.95
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.039-0.078-0.042-0.047-0.011